UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (47) 47
life sciences & biomedicine (46) 46
oncology (38) 38
humans (36) 36
melanoma (30) 30
female (27) 27
male (26) 26
middle aged (26) 26
melanoma - drug therapy (23) 23
aged (22) 22
adult (18) 18
tumors (17) 17
melanoma - pathology (15) 15
aged, 80 and over (14) 14
metastasis (14) 14
patients (14) 14
immunotherapy (13) 13
ipilimumab (13) 13
pembrolizumab (12) 12
melanoma - mortality (11) 11
skin neoplasms - drug therapy (11) 11
antibodies, monoclonal, humanized - therapeutic use (9) 9
cancer (9) 9
clinical trials (9) 9
mutation (9) 9
skin neoplasms - pathology (9) 9
care and treatment (8) 8
research (8) 8
treatment outcome (8) 8
abridged index medicus (7) 7
analysis (7) 7
antibodies, monoclonal, humanized - adverse effects (7) 7
antineoplastic agents, immunological - therapeutic use (7) 7
biological and medical sciences (7) 7
disease-free survival (7) 7
medical sciences (7) 7
neoplasm staging (7) 7
pd-1 protein (7) 7
skin neoplasms - mortality (7) 7
survival (7) 7
antineoplastic agents (6) 6
antineoplastic agents - therapeutic use (6) 6
cancer therapies (6) 6
drug therapy (6) 6
medical research (6) 6
melanoma - genetics (6) 6
melanoma - secondary (6) 6
protein kinase inhibitors - therapeutic use (6) 6
proto-oncogene proteins b-raf - antagonists & inhibitors (6) 6
proto-oncogene proteins b-raf - genetics (6) 6
antibodies, monoclonal - adverse effects (5) 5
antibodies, monoclonal - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
cell biology (5) 5
chemistry (5) 5
chemotherapy (5) 5
confidence intervals (5) 5
dermatology (5) 5
dosage and administration (5) 5
dose-response relationship, drug (5) 5
drug therapy, combination (5) 5
ipilimumab - therapeutic use (5) 5
melanoma - metabolism (5) 5
metastases (5) 5
patient outcomes (5) 5
retrospective studies (5) 5
toxicity (5) 5
adolescent (4) 4
antineoplastic agents - adverse effects (4) 4
antineoplastic agents, immunological - adverse effects (4) 4
biochemistry & molecular biology (4) 4
complications and side effects (4) 4
general & internal medicine (4) 4
health aspects (4) 4
human necessities (4) 4
hygiene (4) 4
immune checkpoint (4) 4
medical or veterinary science (4) 4
medicine, experimental (4) 4
medicine, general & internal (4) 4
medicine, research & experimental (4) 4
metallurgy (4) 4
mitogen-activated protein kinase kinases - antagonists & inhibitors (4) 4
neoplasm metastasis (4) 4
organic chemistry (4) 4
peptides (4) 4
pharmacology. drug treatments (4) 4
prognosis (4) 4
research & experimental medicine (4) 4
skin cancer (4) 4
skin neoplasms - genetics (4) 4
specific therapeutic activity of chemical compounds ormedicinal preparations (4) 4
survival analysis (4) 4
survival rate (4) 4
antibodies (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antibodies, monoclonal, humanized - administration & dosage (3) 3
antimitotic agents (3) 3
antineoplastic agents - pharmacology (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 26, pp. 2521 - 2532
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 10/2018, Volume 362, Issue 6411, p. 197
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 19, pp. 1789 - 1801
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 18, pp. 1694 - 1703
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the skin and soft tissue. Premalignant lesions | Biological and medical sciences | General aspects | Medical sciences | Dermatology | Oximes - pharmacokinetics | Oximes - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Oximes - therapeutic use | Male | Imidazoles - pharmacokinetics | Fever - chemically induced | Drug Therapy, Combination - adverse effects | Melanoma - genetics | Adult | Female | Imidazoles - therapeutic use | Pyridones - pharmacokinetics | Imidazoles - adverse effects | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Melanoma - secondary | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Disease-Free Survival | MAP Kinase Signaling System - drug effects | Pyrimidinones - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Aged | Pyridones - therapeutic use | Mutation | Pyridones - adverse effects | Drugs | Dose-response relationship (Biochemistry) | Usage | Patient outcomes | Melanoma | Product/Service Evaluations | Research | Antineoplastic agents | Antimitotic agents | Gene mutations | Causes of | Genetic aspects | Dosage and administration | Drug therapy, Combination | Drug therapy | Cell survival | Protein kinase | Skin diseases | MAP kinase | Kinases | Patients | Drug dosages | Fever | Metastases | Index Medicus | Abridged Index Medicus
Journal Article